AlphaFold predicted structure
EOGT · Q5NDL2

Mean pLDDT
91.5/ 100
Very high
527 residues
Confidence breakdown
- Very high(≥ 90)83%
- Confident(70–90)10%
- Low(50–70)1%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
EGF domain specific O-linked N-acetylglucosamine transferase
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Clefting
BIALLELIC, autosomal or pseudoautosomalCongenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalLimb disorders
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalAdams-Oliver syndrome
hereditary disease
retinitis pigmentosa
Familial exudative vitreoretinopathy
Cone rod dystrophy
Leber congenital amaurosis
central areolar choroidal dystrophy
age-related macular degeneration
Juvenile glaucoma
angioma serpiginosum
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
EGF domain-specific O-linked N-acetylglucosamine transferase
Catalyzes the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in extracellular proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc). Specifically glycosylates the Thr residue located between the fifth and sixth conserved cysteines of folded EGF-like domains
EOGT · Q5NDL2

Mean pLDDT
91.5/ 100
Very high
527 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0